This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Neurocrine Biosciences, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: David Kucera - Innovator in Neurobiology
Introduction
David Kucera is an inventor based in San Diego, California. He currently works at Neurocrine Biosciences, Inc., where he contributes to advancements in neurobiology. Although he has not yet been granted any patents, his work is focused on significant areas of research that could lead to impactful innovations.
Latest Patent Applications
David Kucera has submitted several notable patent applications. One of his latest applications is titled "CRF Receptor Antagonists and Methods of Use." This application involves compounds that antagonize corticotropin-releasing factor (CRF) receptors, particularly CRF receptor 1. These compounds are aimed at treating diseases and disorders such as congenital adrenal hyperplasia (CAH). Another application is "Processes for the Synthesis of Valbenazine." This application relates to processes for making a specific compound that serves as an inhibitor of vesicular monoamine transporter 2 (VMAT2), which is useful in treating hyperkinetic movement disorders like tardive dyskinesia (TD).
Conclusion
David Kucera is an emerging inventor whose work at Neurocrine Biosciences, Inc. holds promise for future innovations in neurobiology. His latest patent applications reflect his commitment to addressing critical health issues through scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile